BioSpace News Archive

Drug Development

Perle Bioscience Release: Insulin Independence Revolutionary Phase 3 Trial

June 24, 2015
·
2 min read
Drug Development

Celator Pharmaceuticals, Inc. Announces Positive Induction Response Results From Phase 3 Study Of CPX-351 In Patients With High-Risk (Secondary) Acute Myeloid Leukemia

June 24, 2015
·
8 min read
Drug Development

Novo Nordisk A/S Release: In A Phase 3 Trial, Novoeight(Antihemophilic Factor [Recombinant]) Provided Long-Term Efficacy And Safety In The Prophylaxis And Treatment Of Bleeds In People With Hemophilia A

June 24, 2015
·
5 min read
CureVac Announces Study Publication In Molecular Therapy Demonstrating Wide-Ranging Benefits Of Sequence-Optimized, Unmodified mRNAs

June 24, 2015
·
4 min read
Drug Development

Transition Therapeutics Inc. Announces Results Of Clinical Study Of ELND005 In Agitation And Aggression In Patients With Alzheimer’s Disease

June 24, 2015
·
2 min read
Business

Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer

June 24, 2015
·
5 min read
Drug Development

Nuvo Research Inc. Provides Update On International Licensing Of Pennsaid 2%

June 24, 2015
·
6 min read
Viratherapeutics Raises €3.6 Million In The First Closing Of A Series A Financing Round To Advance Its Novel Oncolytic Virus Platform

June 24, 2015
·
6 min read
Calcivis Raises £4.5m To Drive Development Of The Calcivis Caries Activity Imaging System Through To Commercialisation

June 24, 2015
·
4 min read
BioForest

Johnson & Johnson Vision Care, Inc. Introduces 1-DAY ACUVUE MOIST Brand MULTIFOCAL Contact Lenses

June 24, 2015
·
6 min read